BHCM
NAGE

Brevan Howard Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Brevan Howard Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,026
Closed -$167K – 1408
2024
Q1 		$167K Buy
+48,026
New +$167K ﹤0.01% 787